Shukra Pharmaceuticals Ltd Q1FY24 net profit plunges QoQ to Rs. 42.03 lakhs

Shukra Pharmaceuticals Ltd has reported Standalone financial results for the period ended June 30, 2023.

Financial Results (Q1 FY2024) - QoQ Comparison

The company has reported total income of Rs. 20.7937 crores during the period ended June 30, 2023 as compared to Rs. 47.1367 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs. 0.4203 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. 3.9765 crores for the period ended March 31, 2023.

The company has reported EPS of Rs. 0.59 for the period ended June 30, 2023 as compared to Rs. 23.46 for the period ended March 31, 2023.

Financials	Q1 FY2024	Q4 FY2023	% Change
Total Income	₹20.7937 crs	₹47.1367 crs	-55.89%
Net Profit	₹0.4203 crs	₹3.9765 crs	-89.43%
EPS	₹0.59	₹23.46	-97.49%

Financial Results (Q1 FY2024) - YoY Comparison

The company has reported total income of Rs.20.7937 crores during the period ended June 30, 2023 as compared to Rs.6.5738 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs.0.4203 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.0.3279 crores for the period ended June 30, 2022.

The company has reported EPS of Rs.0.59 for the period ended June 30, 2023 as compared to Rs.2.09 for the period ended June 30, 2022.

Financials	Q1 FY2024	Q1 FY2023	% Change
Total Income	₹20.7937 crs	₹6.5738 crs	216.31%
Net Profit	₹0.4203 crs	₹0.3279 crs	28.18%
EPS	₹0.59	₹2.09	-71.77%

Shares of Shukra Pharmaceuticals Ltd was last trading in BSE at Rs. 127.85 as compared to the previous close of Rs. 121.80. The total number of shares traded during the day was 3658 in over 89 trades.

The stock hit an intraday high of Rs. 127.85 and intraday low of 115.75. The net turnover during the day was Rs. 444253.00.

Source : Equity Bulls

Keywords

ShukraPharmaceuticals Q1FY24 ResultUpdate